CXCL10 and pancreatic neoplasm: Notably, the T cell chemokine attractants CCL5, CXCL9 and CXCL10 were increased in DMXAA-treated tumors, macrophages and DCs, as well as KPC1242 epithelial tumor cells, suggesting that these chemokines could participate in the recruitment of T cells to STING agonist-treated pancreatic tumors.